Saw palmetto and lower urinary tract symptoms: What is the latest evidence?
- 1 August 2006
- journal article
- review article
- Published by Springer Nature in Current Urology Reports
- Vol. 7 (4) , 260-265
- https://doi.org/10.1007/s11934-996-0004-2
Abstract
The use of dietary supplements for treating a wide range of health conditions has grown rapidly in the United States. In the field of men’s health, the most common dietary supplement used is an extract of the berry of the saw palmetto plant, with which men commonly selfmedicate in order to treat lower urinary tract symptoms. Throughout the past two decades, substantial literature has emerged examining the biologic and clinical effects of saw palmetto extracts. Several lines of evidence suggest that saw palmetto may exert physiologic effects consistent with a beneficial clinical effect on the mechanisms of benign prostatic hyperplasia. Although most clinical studies tend to suggest a modest efficacy benefit of saw palmetto, more recent studies are less consistent and the precise clinical value of saw palmetto for treating lower urinary tract symptoms remains undefined. Overall, there appear to be few safety concerns with short-term use of this herbal medicine, although large-scale and longer-term safety studies have not been performed. Higher-quality studies are currently underway to better define the potential benefits and risks of plant-based extracts for treating symptoms related to benign prostatic hyperplasia.Keywords
This publication has 42 references indexed in Scilit:
- Analysis of the Inhibitory Potential ofGinkgo biloba,Echinacea purpurea, andSerenoa repenson the Metabolic Activity of Cytochrome P450 3A4, 2D6, and 2C9The Journal of Alternative and Complementary Medicine, 2005
- SERENOA REPENS TREATMENT MODIFIES BAX/BCL-2 INDEX EXPRESSION AND CASPASE-3 ACTIVITY IN PROSTATIC TISSUE FROM PATIENTS WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2005
- Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extractProstate Cancer and Prostatic Diseases, 2004
- Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients—PERMAL Study Subset AnalysisEuropean Urology, 2004
- Analytical Accuracy and Reliability of Commonly Used Nutritional Supplements in Prostate DiseaseJournal of Urology, 2002
- Phytotherapy for benign prostatic hyperplasiaPublic Health Nutrition, 2000
- Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract ofSerenoa repens (LSESr, Permixon ) in benign prostatic hyperplasiaThe Prostate, 2000
- THE SELECTIVITY AND SPECIFICITY OF THE ACTIONS OF THE LIPIDO-STEROLIC EXTRACT OF SERENOA REPENS (PERMIXON®) ON THE PROSTATEJournal of Urology, 2000
- THE SELECTIVITY AND SPECIFICITY OF THE ACTIONS OF THE LIPIDO-STEROLIC EXTRACT OF SERENOA REPENS (PERMIXON??) ON THE PROSTATEJournal of Urology, 2000
- Inhibition of androgen metabolism and binding by a liposterolic extract of “serenoa repens B” in human foreskin fibroblastsJournal of Steroid Biochemistry, 1984